Endo1 Partners, a platform investment of VSS Capital Partners, secured $115 million in debt financing to support its growth trajectory and continued expansion as an endodontic partnership organization (EPO).
Houston-headquartered Endo1 provides non-clinical administrative support for affiliated, independent endodontic practices across 10 states in the U.S. The new debt financing will accelerate the continued growth of the platform and fund future partnerships in its existing and new geographies. Endo1’s back-office infrastructure capabilities provide accounting, billing, business development, human resources, IT, marketing and recruitment services.
“Endo1’s growth trajectory reflects VSS’ proven expertise in transforming traditional, high-demand businesses in alignment with talented management teams and flexible capital,” Jeffrey Stevenson, managing partner of VSS, said. “VSS’ structured capital investments enable our platform companies to accelerate growth, access new resources and expand their business into attractive markets.”
VSS invested in Endo1 in November 2019. To date, Endo1 has added 35 new practices to its network, with additional partnerships already in the pipeline.
“We are pleased to have found in VSS a strategic partner who truly understands the needs, challenges and potential of small businesses poised to grow but constrained by access to capital,” Dr. Daryl Dudum and Dr. Matthew Haddad, co-founders and co-CEOs of Endo1 Partners, said in a joint statement. “We are committed to providing our current and prospective endodontist partners with best-in-class administrative support services so they can focus on providing care that improves patients’ lives while being able to run their practices more efficiently.”
“VSS is excited about the opportunity to support Endo1’s plans to add 50 new locations to its network in 2021, which reflects the foundation we’ve established for the company’s continued growth,” Yash Kandoi, a principal at VSS and leader of VSS’ investment in Endo1, said. “We believe Endo1 is well positioned to meet what we expect will be an increased demand for endodontic procedures in the post-pandemic economy.”
The deal team on Endo1 included Victoria Durand, an associate at VSS who focuses on the firm’s investments in healthcare services.
VSS is a private investment firm investing in the business services, healthcare, education and information industries. It has made investments in 88 portfolio companies, with more than 350 add-on acquisitions, and manages $3.5 billion in aggregate committed capital across seven funds.
